Slaughter MS - Search Results

1

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Lietz K, et al. Among authors: slaughter ms. Circulation. 2007 Jul 31;116(5):497-505. doi: 10.1161/CIRCULATIONAHA.107.691972. Epub 2007 Jul 16. Circulation. 2007. PMID: 17638928

2

Current and potential applications of left ventricular assist devices.

Cianci P, Lonergan-Thomas H, Slaughter M, Silver MA. Cianci P, et al. J Cardiovasc Nurs. 2003 Jan-Mar;18(1):17-22. doi: 10.1097/00005082-200301000-00003. J Cardiovasc Nurs. 2003. PMID: 12537085 Review.

3

Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols.

Slaughter MS, Sobieski MA, Koenig SC, Pappas PS, Tatooles AJ, Silver MA. Slaughter MS, et al. ASAIO J. 2006 May-Jun;52(3):228-33. doi: 10.1097/01.mat.0000208952.73287.41. ASAIO J. 2006. PMID: 16760709

4

Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement.

Feldman CM, Silver MA, Sobieski MA, Slaughter MS. Feldman CM, et al. Among authors: slaughter ms. J Heart Lung Transplant. 2006 Dec;25(12):1410-2. doi: 10.1016/j.healun.2006.10.004. J Heart Lung Transplant. 2006. PMID: 17178333

5

Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.

Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, Sobieski M, Undar A, Farrar DJ, Koenig SC. Travis AR, et al. Among authors: slaughter ms. J Thorac Cardiovasc Surg. 2007 Feb;133(2):517-24. doi: 10.1016/j.jtcvs.2006.09.057. J Thorac Cardiovasc Surg. 2007. PMID: 17258591 Free article.

6

Home discharge experience with the Thoratec TLC-II portable driver.

Slaughter MS, Sobieski MA, Martin M, Dia M, Silver MA. Slaughter MS, et al. ASAIO J. 2007 Mar-Apr;53(2):132-5. doi: 10.1097/MAT.0b013e31802c189e. ASAIO J. 2007. PMID: 17413549

7

Utilization of acoustic signatures to identify HeartMate XVE device end-of-life.

Slaughter MS, Feldman CM, Sobieski MA, Silver MA, Martin MM, Kurien S, Coyle LA, Pederson B. Slaughter MS, et al. J Heart Lung Transplant. 2007 Jun;26(6):579-83. doi: 10.1016/j.healun.2007.03.009. J Heart Lung Transplant. 2007. PMID: 17543780

8

Destination therapy: safety and feasibility of national and international travel.

Coyle LA, Martin MM, Kurien S, Graham JD, Gallagher C, Silver MA, Slaughter MS. Coyle LA, et al. Among authors: slaughter ms. ASAIO J. 2008 Mar-Apr;54(2):172-6. doi: 10.1097/MAT.0b013e318167316d. ASAIO J. 2008. PMID: 18356650

9

Improvement in early oxygen uptake kinetics with left ventricular assist device support.

Feldman CM, Khan SN, Slaughter MS, Sobieski M, Graham JD, Eaheart B, Silver MA. Feldman CM, et al. Among authors: slaughter ms. ASAIO J. 2008 Jul-Aug;54(4):406-11. doi: 10.1097/MAT.0b013e31817e2b79. ASAIO J. 2008. PMID: 18645359

10

Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.

Slaughter MS, Sobieski MA, Gallagher C, Dia M, Silver MA. Slaughter MS, et al. Tex Heart Inst J. 2008;35(3):245-9. Tex Heart Inst J. 2008. PMID: 18941649 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters